Literature DB >> 7687290

Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.

S Z Wang1, E E el-Fakahany.   

Abstract

Chinese hamster ovary cell lines which stably express individual subtypes of muscarinic acetylcholine receptors (m1-m5) were used to assess the potential selectivity of known muscarinic agonists in effecting coupling of different receptor subtypes to signal transduction mechanisms. Phosphoinositide hydrolysis was measured in m1-, m3- and m5-Chinese hamster ovary cells, whereas inhibition of forskolin-mediated cyclic AMP formation was measured upon the activation of m2 and m4 muscarinic receptors. The two muscarinic agonists pilocarpine and McN-A-343 were notably subtype selective on a functional basis. Pilocarpine was more efficacious in stimulating Phosphoinositide hydrolysis linked to m1 as compared to either m3 or m5 muscarinic receptors. On the other hand, McN-A-343 produced marked inhibition of cyclic AMP formation in m4-Chinese hamster ovary cells but only a small response at m2 receptors. The subtype selectivity of pilocarpine and McN-A-343 in these cases was not due to differences in the level of expression of muscarinic receptors in the various cell lines. In contrast, equalizing receptor number in pairs of cell lines masked apparent selectivities in other cases. Our data highlight the functional discrimination of pilocarpine and McN-A-343 among muscarinic receptor subtypes and emphasize the importance of using cell lines which express an equal number of receptors in the process of searching for subtype selective agonists.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687290

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

Review 1.  The muscarinic M(5) receptor: a silent or emerging subtype?

Authors:  R M Eglen; S R Nahorski
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Activation of muscarinic acetylcholine receptors via their allosteric binding sites.

Authors:  J Jakubík; L Bacáková; V Lisá; E E el-Fakahany; S Tucek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Ryoichi Toyoshima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-09       Impact factor: 3.000

5.  Pharmacological discrimination between muscarinic receptor signal transduction cascades with bethanechol chloride.

Authors:  Liwang Liu; Ann R Rittenhouse
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

6.  Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes.

Authors:  Katherine W Figueroa; Michael T Griffin; Frederick J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  2008-09-29       Impact factor: 4.030

7.  Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Neurochem Res       Date:  2008-12-12       Impact factor: 3.996

8.  Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Pharmacology       Date:  2009-04-28       Impact factor: 2.547

9.  Characterization of methanthelinium binding and function at human M1-M5 muscarinic acetylcholine receptors.

Authors:  Matthias Irmen; Janine Holze; Theresa Bödefeld; Christian Tränkle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-24       Impact factor: 3.000

10.  Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.

Authors:  N A Sharif; G W Williams; L M DeSantis
Journal:  Neurochem Res       Date:  1995-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.